Trust analysts at Winterflood have highlighted their favoured biotech and healthcare trusts, as the sector continues its comeback after the threat of significant political reform was reduced following Donald Trump's win in the US Presidential Election a year ago.
The average discount for the AIC's Biotechnology and Healthcare sector has tightened from a weighted average of 5% a year ago to 0% today, while all but one of the funds in existence for more than a year...
Yu Zhang's Matthews Asia Funds China Dividend retains top spot
Latest news and analysis
We are all tired of talking about backstops and customs unions and voting blocs, but Brexit chat still manages to get centre stage to the exclusion of all else.
How to create order amid a seemingly disorderly exit
Part of investment committee restructure